 |
| INC Research CEO Jamie Macdonald--Courtesy INC |
Global CRO INC Research has teamed up with a trade group of clinical research sites, lending its expertise in an effort to better integrate sponsors, CROs and investigators in the R&D process.
INC has inked a two-year partnership with the Society for Clinical Research Sites, which represents about 25,000 investigators and research staff in 22 countries, signing on to help foster better site-to-industry collaborations among the organization's members. The CRO has joined SCRS at its highest membership level, giving it a say in the group's future strategic initiatives.
While the demand for clinical trials has grown steadily, expected to hit $30.7 billion by next year, the industry has a long way to go to harmonize the process. According to INC, 74% to 80% of trial sites around the world perform one clinical trial and then never conduct another. Exacerbating the problem, over the last 15 years, 86% of studies have failed to recruit on time, INC said, creating plenty of room for improvement in the relationship between CROs and sites.
"Developing and maintaining quality relationships with investigative sites around the world is a critical success factor to accelerating the delivery of new medicines to market," INC Research CEO Jamie Macdonald said in a statement. "Joining SCRS is one more way INC Research can demonstrate our commitment to sites by actively collaborating with industry stakeholders on initiatives aimed at establishing best site practices."
And INC believes it's in a position to help. Last year, CenterWatch surveyed more than 2,000 sites around the globe and named INC the most-favored CRO partner after reviewing the results.
- read the statement